News

WRF gifts $2M to ISB to advance P4 Medicine

PRESS RELEASE from Washington Research Foundation:

Sept. 30, 2015, Seattle –– Washington Research Foundation (WRF), which supports groundbreaking technology in the life sciences, physical sciences and information sciences in Washington State, announced today that it will provide the Institute for Systems Biology (ISB) with $2 million in funding to bring increased research power to Seattle, and help place this community at the center of the coming transformation of the health care
system. The funding will help accelerate ISB’s P4 biomedical research, which is catalyzing a new industry – scientific wellness – and establish Seattle as its epicenter. P4 medicine is predictive, preventive,
personalized and participatory and has two central thrusts – quantifying wellness and demystifying disease. The current healthcare industry focuses 98 percent of its efforts and resources on addressing disease. In contrast, P4 medicine will enable the quantification of wellness and promises a revolution in the healthcare system – from a focus on disease to a focus on wellness. This has the potential to save the healthcare systems billions of dollars.

Read full press release…

Recent Articles

  • Autoimmune Disease and Pregnancy: ISB Study Challenges Prevailing Wisdom, Unveils Nuances

    An ISB-led study showed nuanced pregnancy outcomes for pregnant individuals with autoimmune disease. The findings reinforce that there isn’t a one-size-fits-all approach, and provides important new avenues for further investigation.

  • ISB Building at dusk

    2023 Year in Review

    Throughout 2023, ISB research has been published in impactful peer-reviewed journals and our scientists have been featured in major media outlets and popular podcasts. In this 2023 Year in Review, we showcase some of our most important and interesting highlights of the year.

  • Lifestyle coaching improves cognitive decline in Alzheimer's disease trial.

    Personalized Coaching Decreases Cognitive Decline in Early-Stage Alzheimer’s Disease Patients

    Supplementing the standard of treatment for Alzheimer’s disease patients with personalized lifestyle coaching leads to less cognitive decline compared to standard of treatment alone, according to an ISB-led two-year study. The results were published in the Journal of Alzheimer’s Disease.